Clinical Trial Update: Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated celecoxib in combination with recombinant interferon alfa-2b in metastatic renal cell carcinoma after surgery; the study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• CELEBREX (Celecoxib)
• Intron A (interferon alfa-2b)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Renal Cell Cancer, Stage IV Renal Cell Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-07-12